Tranches exactly as the company dimensioned them in its 10-Q filed May 7, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 19.4M underlying shares, as reported Jun 30, 2021 (10-Q).
Balance-sheet fair value of warrants: $0 as of Dec 31, 2021.
Rough fully diluted estimate: 984.1M = 964.7M O/S + 19.4M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Registrations and offerings
S-3ASRMay 2, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
Last 12 months: 4 executed · 0 registered.
EXECUTEDNov 21, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDNov 7, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDNov 6, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDSep 11, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDMay 19, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDMay 9, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.